Moulinath Banerjee Author
Subjects of specialization
Affiliation
Northwestern
Brigham and Women's Hospital Department of Medicine, Hospital of the University of Pennsylvania, Northwestern
University Feinberg School of Medicine, Princeton University, Rush University Medical Center, Yeshiva University Albert Einstein College of Medicine
Brigham and Women's Hospital Department of Medicine, Hospital of the University of Pennsylvania, Northwestern
Commentary Subscription
Author(s): Moulinath Banerjee
Sodium glucose co-transporter 2 inhibitors are a new group of drugs available to treat patients with type 2 diabetes mellitus. Recently, FDA has sounded a warning of higher risk of Diabetes ketoacidosis among patients treated with this group of agents. This article reviews the available evidence to build a potential hypothesis to explain the development of this complication.
... view moreĀ»